Agilon Health (AGL) closed at $113.39 on November 6, 2026, down 0.3% from the previous close, on volume of 244,598 shares (30-day average 212,893).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Put with Delta Hedge | 20-Nov-26 85 P +1,920 Stock | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Business Wire (Thu, 5-Nov 7:30 AM ET)
Agilon Health (AGL) Gets a Hold from Barclays
TipRanks (Thu, 5-Nov 3:41 AM ET)
agilon health Non-GAAP EPS of $1.97 beats by $2.70, revenue of $1.52B beats by $60M
Seeking Alpha News (Wed, 4-Nov 4:30 PM ET)
agilon health Reports Third Quarter 2026 Results
Business Wire (Wed, 4-Nov 4:05 PM ET)
agilon health Sets Date to Report Third Quarter 2026 Financial Results
Business Wire (Mon, 5-Oct 4:05 PM ET)
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Business Wire (Wed, 30-Sep 9:00 AM ET)
Market Chameleon (Thu, 24-Sep 7:51 AM ET)
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
Business Wire (Wed, 23-Sep 9:00 AM ET)
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
Business Wire (Thu, 10-Sep 9:00 AM ET)
Business Wire (Thu, 27-Aug 4:05 PM ET)
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of November 6, 2026, AGL stock price declined to $113.39 with 244,598 million shares trading.
AGL has a beta of 4.77, meaning it tends to be more sensitive to market movements. AGL has a correlation of 0.14 to the broad based SPY ETF.
AGL has a market cap of $1.89 billion. This is considered a Small Cap stock.
Last quarter Agilon Health reported $2 billion in Revenue and $1.97 earnings per share. This beat revenue expectation by $60 million and exceeded earnings estimates by $2.96.
In the last 3 years, AGL traded as high as $349.50 and as low as $7.48.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): IWM, VTI, FNDA, IWO, FYC.
AGL has outperformed the market in the last year with a price return of +550.5% while the SPY ETF gained +10.8%. AGL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +30.6% and +26.4%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
AGL support price is $107.44 and resistance is $120.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL shares will trade within this expected range on the day.
